SEC. 2. GRANTS FOR SAME-DAY POINT-OF-CARE TESTING 
IN COMMUNITIES. 
Section 2821 of the Public Health Service Act (42 
U.S.C. 300hh–31) is amended— 
(1) by redesignating subsection (b) as sub-
section (d); and 
(2) after making such redesignation, by insert-
ing after subsection (a) the following new subsection: 
‘‘(b) GRANTS FOR SAME-DAY POINT-OF-CARE TEST-
ING IN COMMUNITIES.— 
‘‘(1) GRANTS.—The Secretary, acting through 
the Director of the Centers for Disease Control and 
Prevention, shall award grants to eligible entities to 
assist such entities in acquiring legally-marketed 
equipment and supplies capable of performing, stor-
ing, and processing same-day clinical laboratory test-
ing, including molecular, serological, and antigen 
tests, in a point-of-care setting. 
‘‘(2) ELIGIBILITY.—To be eligible for a grant 
under paragraph (1), an entity shall— 
‘‘(A) be— 
‘‘(i) a hospital; 
‘‘(ii) a primary care facility; 
‘‘(iii) a clinic; 
‘‘(iv) a pharmacy; 
‘‘(v) a physician; or 
VerDate Sep 11 2014 
22:08 Feb 22, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H747.IH
H747
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(vi) such other type of health care 
provider as the Secretary may determine 
for purposes of this section; 
‘‘(B) be in compliance with section 353 
(commonly referred to as the ‘Clinical Labora-
tory Improvement Amendments of 1988’); and 
‘‘(C) submit to the Secretary an applica-
tion at such time, in such manner, and con-
taining such information as the Secretary may 
reasonably require. 
‘‘(3) AMOUNT OF GRANT.—The amount of a 
grant under paragraph (1) may not exceed $20,000. 
‘‘(4) PRIORITY.—In awarding grants under 
paragraph (1), the Secretary shall give highest pri-
ority to eligible entities providing services to— 
‘‘(A) underserved populations in rural 
areas; and 
‘‘(B) medically underserved populations (as 
defined in section 330(b)(3)).’’. 
SEC. 3. GRANTS FOR LABORATORIES TO ACQUIRE HIGH- 
THROUGHPUT DIAGNOSTIC EQUIPMENT. 
Section 2821 of the Public Health Service Act (42 
U.S.C. 300hh–31) is amended by inserting after sub-
section (b) (as added by section 2) the following new sub-
section: 
VerDate Sep 11 2014 
22:08 Feb 22, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H747.IH
H747
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(c) GRANTS
FOR
LABORATORIES
TO
ACQUIRE 
HIGH-THROUGHPUT DIAGNOSTIC EQUIPMENT.— 
‘‘(1) GRANTS.—The Secretary, acting through 
the Director of the Centers for Disease Control and 
Prevention, shall award grants to eligible entities to 
assist such entities in purchasing high-throughput 
diagnostic equipment and related supplies to admin-
ister, store, and process molecular, serological, and 
antigen tests. 
‘‘(2) ELIGIBILITY.—To be eligible for a grant 
under paragraph (1), an entity shall— 
‘‘(A) be— 
‘‘(i) a State, local, or Tribal public 
health laboratory; 
‘‘(ii) a laboratory within a public 
health laboratory network coordinated or 
managed by the Centers for Disease Con-
trol and Prevention; 
‘‘(iii) a laboratory not described in 
clause (i) or (ii) that the Secretary deter-
mines (at the Secretary’s discretion) pro-
vides population-based testing for the pre-
vention and control of infectious, commu-
nicable, genetic, or chronic diseases; or 
VerDate Sep 11 2014 
22:08 Feb 22, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H747.IH
H747
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(iv) a consortium of 2 or more enti-
ties described in any of clauses (i) through 
(iii); and 
‘‘(B) submit to the Secretary an applica-
tion at such time, in such manner, and con-
taining such information as the Secretary may 
reasonably require. 
‘‘(3) AMOUNT OF GRANT.—The amount of a 
grant under paragraph (1) may not exceed 
$2,000,000, except in the case of eligible entity de-
scribed in paragraph (2)(A)(iv). 
‘‘(4) HIGH-THROUGHPUT
DIAGNOSTIC
EQUIP-
MENT DEFINED.—In this subsection, the term ‘high- 
throughput diagnostic equipment’ means legally- 
marketed equipment capable of performing multi-
channel analysis for use in clinical laboratory test-
ing, including molecular, serological, and antigen 
tests.’’. 
SEC. 4. AUTHORIZATION OF APPROPRIATIONS. 
Section 2821(d) of the Public Health Service Act (42 
U.S.C. 300hh–31(d)) (as redesignated by section 2) is 
amended to read as follows: 
(1) by striking ‘‘There are authorized to be ap-
propriated to carry out this section’’ and inserting 
the following: 
VerDate Sep 11 2014 
22:08 Feb 22, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H747.IH
H747
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(1) IN GENERAL.—There is authorized to be 
appropriated to carry out subsection (a)’’; and 
(2) by adding at the end, the following: 
‘‘(2) AUTHORIZATION OF APPROPRIATIONS.— 
‘‘(A) TESTING GRANTS.—For carrying out 
subsection (b), there is authorized to be appro-
priated $500,000,000 for fiscal year 2021, to 
remain available until expended. 
‘‘(B) EQUIPMENT GRANTS.—For carrying 
out subsection (c), there is authorized to be ap-
propriated $250,000,000 for fiscal year 2021, 
to remain available until expended. 
‘‘(C) ADMINISTRATIVE EXPENSES.—Of the 
total amount made available to carry out sub-
sections (b) and (c) for any fiscal year, the Sec-
retary may not use more than 5 percent of such 
amount for the expenses of administering such 
subsections.’’. 
Æ 
VerDate Sep 11 2014 
22:08 Feb 22, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H747.IH
H747
pamtmann on DSKBC07HB2PROD with BILLS